# FLUXID
> **NDA021712** · New Drug Application · Sponsor: UCB INC · Approved 2004-09-24
## Drug
- **FDA Application Number:** NDA021712
- **Application type:** New Drug Application
- **Brand name:** FLUXID
- **Generic name:** Famotidine
- **Active ingredients:** FAMOTIDINE
- **Dosage form:** TABLET, ORALLY DISINTEGRATING
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** UCB INC
- **First approval:** 2004-09-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021712)
---
*AI Analytics · CC0 1.0*